Volume 1, Number 4Book ReviewsBasic and Well Beyond in Pediatric SurgeryPediatric SurgeryPatrick McKenna
Volume 1, Number 4Book ReviewsComprehensive Review of Reconstructive SurgeryUrologic SurgeryR Duane Cespedes
Volume 2, Number 1Book ReviewsClinically Relevant Insights on Testicular and Penile CancerOncologyFarhang Rabbani
Volume 14, Number 3Book Reviewsa-Blockers for the Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome: An Update on Current Clinical EvidenceTreatment UpdateJ Curtis NickelNaji ToumaThe pathogenesis of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is multifactorial, making its treatment difficult. Multimodal therapy including a- adrenergic antagonists (a-blockers), anti-inflammatory agents, and other pain treatments may provide optimal management for CP/CPPS. Although a-blockers are the most prescribed drugs for patients with CP/CPPS, not all studies support their efficacy. A recent meta-analysis of small trials suggested that treatment with a-blockers, possibly in combination with antibacterial agents, is efficacious in relieving symptoms. Third-generation a1A blockers (silodosin, tamsulosin) may provide efficacy as well as reduced cardiovascular side effects. Future research should aim to identify potential biomarkers associated with treatment response. [Rev Urol. 2012;14(3/4):56-64 doi: 10.3909/riu0557] © 2013 MedReviews®, LLCAdrenergic alpha-1 receptor antagonistsTamsulosinSilodosinAlfuzosinProstatitis
Volume 17, Number 4Book ReviewsSmoking: Its Impact on Urologic HealthManagement UpdateNeil BaumDavid MobleyTobacco use remains the single largest preventable cause of disease and premature death in the United States, and smoking is a leading cause of cancer and death from cancer. There is also evidence that smoking is associated with several urologic diseases. Urologists have a unique opportunity to help our patients lead healthy lifestyles, which includes ending their dependence on nicotine and tobacco. This article points out the various urologic conditions associated with smoking and tobacco use with the intention of providing physicians and patients with knowledge and education regarding this connection. [Rev Urol. 2015;17(4):220-225 doi: 10.3909/riu0684] © 2016 MedReviews®, LLCProstate cancerBladder cancerKidney cancerInterstitial cystitisSmokingErectile dysfunction
Volume 17, Number 2Book ReviewsA Review of Transplantation Practice of the Urologic Organs: Is It Only Achievable for the Kidney?Treatment UpdateJack Donati-BourneHarry W RobertsYaseen RajjoubRobert A ColemanTransplantation is a viable treatment option for failure of most major organs. Within urology, transplantation of the kidney and ureter are well documented; however, evidence supporting transplantation of other urologic organs is limited. Failure of these organs carries significant morbidity, and transplantation may have a role in management. This article reviews the knowledge, research, and literature surrounding transplantation of each of the urologic organs. Transplantation of the penis, testicle, urethra, vas deferens, and bladder is discussed. Transplantation attempts have been made individually with each of these organs. Penile transplantation has only been performed once in a human. Testicular transplantation research was intertwined with unethical lucrative pursuits. Interest in urethra, bladder, and vas deferens transplantation has decreased as a result of successful surgical reconstructive techniques. Despite years of effort, transplantations of the penis, testicle, urethra, vas deferens, and bladder are not established in current practice. Recent research has shifted toward techniques of reconstruction, tissue engineering, and regenerative medicine. [Rev Urol. 2015;17(2):69–77 doi: 10.3909/riu0659] © 2015 MedReviews®, LLCUrologyTransplantationReconstructionTissue engineering